Abiopharma

Clinical trial NCT03890237: enrollment: not set → 4500 participants.

Clinical trial NCT06300411 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-10 → 2026-04-08 3. primary completion date: 2026-04-10 → 2026-04-08 4. enrollment: not set → 25 participants

Clinical trial NCT07607301: enrollment: not set → 96 participants.

Clinical trial NCT04064060: enrollment: not set → 665 participants.

Clinical trial NCT04896008: enrollment: not set → 173 participants.

Clinical trial NCT06687746 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-01 → 2026-03-03 3. primary completion date: 2026-04-01 → 2026-03-03 4. enrollment: not set → 4060 participants

Clinical trial NCT07290283: enrollment: not set → 176 participants.

The company’s outstanding liabilities as of March 31, 2026, by maturity dates

Clinical trial NCT06455449: enrollment: not set → 240 participants.

Clinical trial NCT07607743: enrollment: not set → 240 participants.